NCT07807930

Brief Summary

Electroconvulsive therapy (ECT) and transcranial magnetic stimulation (TMS) are two evidence-based treatments for major depressive disorder. Both work by stimulating the brain (a process known as neuromodulation), but they differ markedly in invasiveness. ECT requires a general anaesthetic, whereas TMS is delivered while a person is awake and alert and they can go home immediately afterwards. TMS has been proposed as an alternative to ECT for some people. However, TMS is not as effective as ECT in all cases, is generally slower acting, and remains less widely available. In Nottingham and Liverpool, there are a small number of individuals who have experienced both ECT and TMS across different episodes of depression. Whilst previous studies have explored experiences of ECT and TMS separately, often using relatively superficial methods, none have examined the perspectives of people who have received both treatments. This study addresses that gap through an in-depth exploration of their experiences. The investigators will use a narrative inquiry approach that encourages participants to tell the story of their experiences of ECT and TMS in their own words. Eligible participants will be adults who have previously received both treatments for depression. Participation involves four sessions: a structured discussion to map the timeline of their depression and treatments, two in-depth open-ended interview sessions (narrative inquiry), and a follow-up discussion about the researchers' reconstruction of their story. Recruitment will take place through services in Nottingham and Liverpool. This study will help to understand how patients relate to, and make sense of, ECT and TMS, which contextual factors shape their experiences, and how these treatments fit into broader recovery journeys. The findings will inform the development of patient-centred services, support shared decision-making, and help healthcare professionals deepen compassionate understanding of treatment experiences.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for all trials

Timeline
12mo left

Started Nov 2026

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 1, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 8, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

November 1, 2026

Expected
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2027

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2027

Last Updated

September 30, 2026

Status Verified

August 1, 2026

Enrollment Period

12 months

First QC Date

September 1, 2026

Last Update Submit

September 28, 2026

Conditions

Keywords

Narrative inquiryQualitative interviewsTranscranial magnetic stimulation (TMS)Electroconvulsive therapy (ECT)Lived experience

Outcome Measures

Primary Outcomes (1)

  • Co-created narratives and associated themes

    From enrollment to the completion of the follow-up feedback sesson

Study Arms (1)

People with lived experience of both ECT and TMS for treating major depression

Other: There is no intervention in this observation study (qualitative interviews about past treatment experiences)

Interventions

There is no intervention in this observation study (qualitative interviews about past treatment experiences)

People with lived experience of both ECT and TMS for treating major depression

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults who have received at least one session of TMS in Nottingham or Liverpool, who have also received at least one session of ECT, both intended to treat an episode of major depression

You may qualify if:

  • years or older
  • Previously received at least one TMS and one ECT session as treatment for major depression
  • Conversational in the English language
  • Capacity to give informed consent to take part in this study
  • Feels fully informed and well enough to be able to share potentially distressing past experiences

You may not qualify if:

  • Participants may be excluded at the judgement of the PI if it is felt that the participant is at high risk of significant emotional distress from taking part in the interviews at this time

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Mersey Care NHS Foundation Trust

Liverpool, United Kingdom

Location

University of Nottingham

Nottingham, United Kingdom

Location

MeSH Terms

Conditions

Depressive Disorder, Major

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental Disorders

Study Officials

  • Paul M Briley

    University of Nottingham

    PRINCIPAL INVESTIGATOR
  • Jade Thai

    Mersey Care NHS Foundation Trust

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sarah Research Assistant (Nottingham)

CONTACT

Peggy Research Assistant (Liverpool)

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 1, 2026

First Posted

September 8, 2026

Study Start (Estimated)

November 1, 2026

Primary Completion (Estimated)

October 31, 2027

Study Completion (Estimated)

October 31, 2027

Last Updated

September 30, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Locations